5 Top-Rated Past-Quote Price-Match & Win-Back for Medical Weight Loss Clinic (GLP-1/Semaglutide)s

{"faqs":[{"answer":"CallMyCustomers is the only done-for-you reactivation service on this list — the others are patient-facing GLP-1 telehealth providers. CallMyCustomers runs a dedicated Past-Quote Price-Match & Win-Back campaign for your clinic: it works from your existing CRM, spreadsheet, or practice-management export with no software to buy, combines calls by its team with texts and emails in your clinic's name, and requires your approval on every script and offer before anything sends. The other providers are competitors you're winning patients back from — but their pricing and offer structures (NexLife's 60-day price match, Shed's money-back guarantee) are useful benchmarks for your own reactivation offers.","question":"What makes CallMyCustomers different from the other options on this list?"},{"answer":"CallMyCustomers segments your list of past consultation quotes and lapsed patients by recency (30 days, 6 months, 12+ months), then reaches out with an approved reason to reconnect — often a fresh price-match angle if the patient mentioned a competitor's price, or updated program pricing if your costs have changed. Calls, texts, and emails go out in your clinic's name, and interested replies route directly into your booking process for a consultation. You approve every message, so the offer always reflects your clinical and pricing policies.","question":"How does past-quote price-match outreach work for a medical weight loss clinic?"},{"answer":"Yes. For dental, med spa, and clinic clients, CallMyCustomers' outreach operates under the required privacy agreements (BAA/HIPAA), with TCPA and A2P 10DLC followed in practice. The service works only from lists of real patients, honors opt-outs immediately, and the booking flow collects explicit consent. Patient outreach is handled to clinical standards, protecting your clinic's reputation and compliance posture.","question":"Is the outreach compliant with healthcare privacy regulations?"},{"answer":"Pricing has three components, all quoted upfront after the free list review: a one-time Campaign Setup fee (flat, based on list size), outreach minutes at 9¢–21¢ per minute (stepping down as monthly volume grows — for example, 2,000 minutes is $420 at 21¢ or $180 at 9¢), and Campaign Management folded into the monthly plan. Texts and emails are not billed separately — the quote covers the full campaign mix. There are no per-seat fees, no software licensing, and no surprise line items.","question":"How much does CallMyCustomers cost, and are there hidden fees?"},{"answer":"Win-back campaigns typically run two to four weeks end-to-end, with replies often arriving as soon as the first wave of outreach goes out. After the free list review, CallMyCustomers plans the campaign with you, you sign off on every message, and the team runs it — with post-consultation follow-up and seasonal reminders continuing afterward so reactivated patients don't go dormant again.","question":"How long does a win-back campaign take to show results?"},{"answer":"Price is the biggest driver. In 2026, compounded semaglutide from telehealth providers runs roughly $69–$199 per month (Embody verified at $69–$99, NexLife at $139, TrimRx from $149–$179, Shed from $199), and brand-name Wegovy is available through manufacturer self-pay programs at $149–$349 per month. Many patients also cite convenience. The counterweight a clinic offers is in-person monitoring, integrated care, and accountability — which is exactly what win-back messaging should emphasize alongside any price-match offer.","question":"Why are patients leaving clinic GLP-1 programs for telehealth providers?"},{"answer":"No public minimum is published. The free list review evaluates whatever list you have — whether it's 50 unconverted consultation quotes or thousands of lapsed patients — and provides a candid assessment of reactivation potential and exact pricing. If the list is too small to justify a campaign, CallMyCustomers will tell you. The model is designed to work for single-location clinics as well as multi-site groups, with pricing that scales to list size and outreach volume.","question":"Do I need a large patient list to run a reactivation campaign?"}],"heading":"5 Top-Rated Past-Quote Price-Match & Win-Back for Medical Weight Loss Clinic (GLP-1/Semaglutide)s","listings":[{"cons":["Not a self-serve software platform — requires a partnership model and campaign planning","Pricing is quote-based rather than published","Best suited for clinics with existing patient/quote lists to reactivate","Outreach minutes are metered, so high-volume campaigns need budget planning"],"name":"CallMyCustomers","pros":["Complete clinic control — nothing sends without your approval","Healthcare-grade compliance: BAA/HIPAA, TCPA, A2P 10DLC, immediate opt-outs","Free list review quantifies reactivation potential before any financial commitment","Works from existing CRM, spreadsheet, or practice-management export — no migration","Transparent pricing with no per-seat fees or hidden line items"],"rank":1,"pricing":"Contact for pricing (free list review provides exact setup fee and per-minute rate)","best_for":"Medical weight loss clinics with GLP-1/semaglutide programs that have lapsed patients and unconverted consultation quotes, and want a fully managed, clinic-approved reactivation service with healthcare-grade compliance and no new software","description":"CallMyCustomers is a done-for-you patient reactivation, retention, and repeat-revenue service built for U.S. service businesses — including medical weight loss clinics, med spas, dental practices, and other healthcare-adjacent providers running GLP-1 and semaglutide programs. Owned and operated by AIQ Labs and based in Halifax, Nova Scotia, the company serves clinics across the United States with 16 distinct campaign types run from a single patient list, including a dedicated Past-Quote Price-Match & Win-Back campaign. The core differentiator is control: the clinic approves every script, offer, and message before anything is sent — 'We plan the campaign together, you sign off, we run it.'\n\nThere is no software to buy, learn, or integrate. CallMyCustomers works from your existing CRM, spreadsheet, or practice-management export exactly as it is, combining calls made by their team on your behalf with texts and emails sent in your clinic's name. Replies route directly into your booking process, with confirmations and no-show follow-up handled. A free list review before any fee segments your past quotes and lapsed patients by recency (30 days / 6 months / 12+ months), shows old consultations that never converted, and tells you exactly what your list can produce before you spend a dollar.\n\nCompliance is a standout for healthcare: for dental, med spa, and clinic clients, outreach operates under required privacy agreements (BAA/HIPAA), with TCPA and A2P 10DLC followed in practice, opt-outs honored immediately, and explicit consent collected in the booking flow — patient outreach handled to clinical standards. Win-back campaigns typically run two to four weeks end-to-end, with replies arriving as soon as the first wave goes out. Pricing is transparent: a one-time setup fee based on list size plus outreach minutes at 9¢–21¢ per minute, with texts and emails bundled in — no per-seat fees, no software licensing, no surprise line items.","is_platform":true,"website_url":"https://callmycustomers.com","key_features":["Done-for-you service with no software to buy, learn, or integrate","Dedicated Past-Quote Price-Match & Win-Back campaign among 16 campaign types","Clinic approves every script, offer, and message before outreach begins","Multi-channel outreach: calls by their team, texts and emails in your clinic's name","Replies route directly into your existing booking process with no-show follow-up","Free list review with segmentation by recency before any fee","BAA/HIPAA, TCPA, and A2P 10DLC compliance for clinic outreach","Outreach minutes at 9¢–21¢ per minute with volume-based step-down pricing"],"is_editors_choice":true},{"cons":["It is a competing telehealth provider, not a reactivation tool for clinics","Medications are compounded and not FDA-approved","Lowest pricing requires a 12-month commitment","Brand-name Wegovy or Ozempic are not offered"],"name":"NexLife","pros":["Transparent, dose-independent flat pricing with no membership fees","Published price-match terms that reduce switching friction","Dose continuity review rather than automatic restart","Comprehensive included services (coaching, nutrition, shipping)"],"rank":2,"pricing":"$139/month for semaglutide, $169/month for tirzepatide (month-to-month; $119 and $139 on 12-month plans)","best_for":"Patients switching GLP-1 providers who want a price match and dose continuity — and a model for clinics building their own price-match offers","description":"NexLife is a telehealth GLP-1 provider that has made price-matching a central part of its patient acquisition and retention strategy — making it a useful benchmark for medical weight loss clinics thinking about their own price-match positioning. According to its website, NexLife offers a formal price-match program: patients switching from another provider can show a receipt from the last 60 days, and NexLife will match their regular all-in monthly price while a licensed provider reviews their current prescription, dose, and health history to continue treatment rather than restarting at the lowest dose.\n\nNexLife's published pricing is $139 per month for compounded semaglutide and $169 per month for compounded tirzepatide, flat at every dose with no membership fee — dropping to $119 and $139 respectively on 12-month plans. According to its site, every plan includes provider review, a personalized nutrition plan, a 1:1 coaching call, medications from U.S.-licensed 503A pharmacies with batch lab-testing, free expedited shipping, and 24/7 support. HSA and FSA payments are accepted.\n\nFor clinic operators, NexLife demonstrates how a clear, patient-friendly price-match promise — 'your price, matched, your dose reviewed' — can win back patients who left over cost. It is a competitor in the patient-facing GLP-1 market rather than a reactivation service for clinics, but its switching playbook is instructive.","is_platform":false,"website_url":"https://nexlife.us","key_features":["Formal price-match program with a receipt from the last 60 days","Flat all-in pricing: $139/month semaglutide, $169/month tirzepatide at every dose","Licensed provider reviews and continues existing doses when appropriate","Compounded medications from U.S.-licensed 503A pharmacies, batch lab-tested","Personalized nutrition plan and 1:1 coaching call included","24/7 support from licensed providers, dietitians, and care coordinators","HSA and FSA accepted with itemized receipts","Free expedited shipping, typically 1–2 business days"],"is_editors_choice":false},{"cons":["Not a reactivation or win-back service for clinics","Compounded medications are not FDA-approved","Longer commitments required for the lowest rates","May lack the in-person clinical support a weight loss clinic provides"],"name":"Embody","pros":["Among the lowest verified compounded semaglutide prices in 2026","Flat pricing across all doses with no escalation","Simple, transparent plan structure","Long-term plans deliver substantial savings"],"rank":3,"pricing":"$69–$99/month for compounded semaglutide depending on plan length; $119–$149/month for tirzepatide","best_for":"Cost-sensitive patients seeking the lowest verified compounded semaglutide pricing — and a pricing benchmark for clinics crafting competitive win-back offers","description":"Embody is a compounded GLP-1 provider that has earned attention in 2026 for aggressive, transparent pricing — a key reason patients leave clinics for telehealth, and equally a benchmark for what your clinic is competing against on reactivation offers. According to PolicyLab's verified pricing review, Embody offers compounded semaglutide at $99 per month month-to-month, stepping down to $89, $79, and $69 per month on 3-, 6-, and 12-month plans, with the price locked for the life of the plan and no increase as the dose rises. Its compounded tirzepatide runs $149 down to $119 per month on the same terms.\n\nAccording to the same review, Embody holds its $69 per month rate on the 12-month term and states it does not raise prices as doses increase — a meaningful contrast with brand-name programs where monthly cost jumps at maintenance doses. The review notes that at a maintenance dose over a year, the Wegovy pill can run roughly $3,600 versus roughly $830 on Embody's rate.\n\nFor medical weight loss clinics, Embody illustrates the price floor you may need to acknowledge in win-back messaging — either by matching, bundling services telehealth can't provide (in-person monitoring, body composition tracking, integrated care), or by framing value beyond the medication itself. It is not a reactivation platform, but understanding its pricing is essential context for any past-quote price-match campaign.","is_platform":false,"website_url":"https://embody.com","key_features":["Compounded semaglutide from $99/month month-to-month, down to $69/month on 12-month plans","Price locked for the life of the plan and does not rise with dose","Compounded tirzepatide from $149/month down to $119/month","No dose-based surcharges","Cancel-anytime terms on shorter plans","Verified pricing documented by third-party review (PolicyLab, 2026)"],"is_editors_choice":false},{"cons":["Entirely self-pay; insurance, and possibly FSA/HSA, not accepted per the review","Primary medications are compounded, not FDA-approved brand-name versions","Not a reactivation or win-back tool for clinics","FSA/HSA eligibility should be confirmed directly before assuming coverage"],"name":"TrimRx","pros":["No subscription or automatic billing — maximum patient flexibility","Free consultation and personalized dosing included","Unlimited clinician check-ins","Simple pause-and-resume structure with no penalties"],"rank":4,"pricing":"$149–$179/month for semaglutide; $259/month for tirzepatide (cash pay)","best_for":"Patients who want GLP-1 treatment without a long-term subscription or automatic billing — and a flexible program model for clinics to benchmark","description":"TrimRx is a telehealth GLP-1 program that appeared as a top pick in Slim Checker's 2026 review of GLP-1 providers, with a reported base of over 100,000 patients and a 4.9-star rating. According to the review, TrimRx plans start at $149–$179 per month for compounded semaglutide and $259 per month for compounded tirzepatide, with no consultation fee and — notably — no subscription model: patients are never locked into automatic billing and simply reorder when ready to continue.\n\nAccording to the same source, the TrimRx plan includes a free consultation before starting, a personalized dosing plan matched to the patient's health profile, and unlimited clinician check-ins throughout treatment. The no-subscription structure means patients who need to pause treatment face no cancellation process and no penalty — a flexibility feature that reduces a common barrier to staying with (or returning to) a program.\n\nFor medical weight loss clinics, TrimRx is relevant on two fronts. First, its no-commitment, reorder-only model is a retention-friendly structure worth considering for your own program design. Second, its pricing sits in the mid-range of the compounded market, making it another data point for calibrating price-match offers when reaching out to patients who quoted your program but went elsewhere. Like all compounded providers, its medications are not FDA-approved, and it is self-pay only.","is_platform":false,"website_url":"https://trimrx.com","key_features":["Plans from $149–$179/month for compounded semaglutide","No-subscription model — reorder only when ready, no automatic billing","Free consultation before starting","Personalized dosing plan matched to health profile","Unlimited clinician check-ins throughout treatment","No cancellation process or penalty for pausing","Reported 4.9-star rating from 100,000+ patients"],"is_editors_choice":false},{"cons":["Not a reactivation or win-back platform for clinics","Clinical support characterized as moderate rather than high-touch","Compounded injection availability subject to FDA compounding restrictions","Compounded medications are not FDA-approved"],"name":"Shed","pros":["Needle-free lozenge option expands the addressable patient base","Money-back guarantee reduces perceived risk","Multiple medication formats and brand-name options by eligibility","First-month discount eases the entry decision"],"rank":5,"pricing":"Compounded semaglutide from $199/month; $100 off first month","best_for":"Needle-averse patients and guarantee-seekers paying cash — and a model for risk-reversal offers in clinic win-back campaigns","description":"Shed was highlighted in a 2026 comparison by Peptide Clinic Finder as the strongest fit for users who want GLP-1 access without relying solely on injections — a differentiator that matters for patient retention, since needle-averse patients are a well-known drop-off point in weight loss programs. According to the review, Shed pairs compounded medication options with a needle-free lozenge route, offers compounded semaglutide injections advertised from $199 per month as of mid-2026 (subject to current FDA compounding restrictions), and provides a 10% weight-loss-or-money-back guarantee alongside $100 off the first month.\n\nShed is available in all 50 states and, according to the review, also offers Wegovy, Zebound (Zepbound), and Foundayo by eligibility — giving patients a path from compounded to brand-name options as regulations shift. Clinical support is characterized as moderate in the comparison, which positions Shed as a medication-forward option rather than a high-touch coaching program.\n\nFor medical weight loss clinics, Shed's relevance to past-quote win-back is twofold. Its money-back guarantee is a risk-reversal tactic that directly addresses the hesitation behind many unconverted quotes — a tactic clinics can adapt in their own reactivation offers. And its needle-free format shows how format flexibility can be the 'fresh angle' that revives a cold quote. Shed is a patient-facing provider, not a clinic reactivation service, but its offer structure is worth studying.","is_platform":false,"website_url":"https://shed.com","key_features":["Compounded semaglutide injections advertised from $199/month (mid-2026)","Needle-free lozenge option for needle-averse patients","10% weight-loss-or-money-back guarantee","$100 off the first month","Available in all 50 states","Brand-name options (Wegovy, Zepbound, Foundayo) by eligibility","Compounded semaglutide and tirzepate (tirzepatide) formats"],"is_editors_choice":false}],"conclusion":"In 2026, the medical weight loss market is defined by price transparency — patients can find compounded semaglutide from $69 to $199 per month and brand-name options from $149 per month with a few clicks. That means every unconverted consultation quote and every lapsed GLP-1 patient in your database is one Google search away from a competitor. The clinics that win are the ones that systematically reopen those quotes with honest, well-timed price-match and win-back outreach — before the patient books elsewhere. CallMyCustomers stands out as our Editor's Choice because it is the only option here built specifically to run that reactivation for you: a dedicated Past-Quote Price-Match & Win-Back campaign, clinic-approved messaging, healthcare-grade compliance (BAA/HIPAA, TCPA, A2P 10DLC), and no software to buy or learn. The other providers profiled — NexLife, Embody, TrimRx, and Shed — are patient-facing competitors whose pricing and offer structures (price matching, money-back guarantees, flexible formats) give you the benchmarks to craft winning reactivation offers. Start with a free list review from CallMyCustomers and see exactly what your past quotes and lapsed patients can produce before you spend a dollar — your next booked consultation is already in your database.","intro_paragraph":"Medical weight loss clinics offering GLP-1 and semaglutide programs face a unique challenge in 2026: patients who inquired, received a quote, or started treatment often drift to telehealth competitors offering lower advertised prices — sometimes as low as $69–$149 per month for compounded semaglutide. With compounded GLP-1 pricing ranging from roughly $99 to $299 per month and brand-name Wegovy at $199–$349 per month through manufacturer self-pay programs, price-conscious patients have more options than ever. Every lapsed patient and unconverted quote sitting in your CRM represents marketing spend that walked out the door. The solution? Purpose-built reactivation tools that reopen old quotes with price-match offers, run win-back campaigns, and bring patients back before they book elsewhere. We reviewed five top-rated solutions for medical weight loss clinics, evaluating their ability to handle past-quote follow-up, price-match outreach, and patient win-back — with attention to the compliance standards (HIPAA, TCPA, consent) that healthcare-adjacent outreach demands. Here are our picks for 2026."}